Special Issue "Inflammatory Bowel Disease: Advancement in Diagnosis and Medical Management"
Deadline for manuscript submissions: closed (15 June 2023) | Viewed by 5204
Interests: inflammatory bowel disease; pediatrics; pharmacogenomics, translational medicine, intestinal organoids
Special Issues, Collections and Topics in MDPI journals
2. Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy
Interests: pharmacogenetics; pharmacokinetics; pediatrics; inflammatory chronic diseases; acute lymphoblastic leukemia
The diagnosis, monitoring, and surveillance of IBD patients require a personalized evaluation to guide treatment decisions. To date, a curative pharmacological therapy for IBD does not exist and the therapeutic approach is mainly aimed at the treatment and control of inflammation, through drugs capable of inducing and maintaining remission. Given the lack of clinical predictors, patients are still treated by using a “one size fits all” approach. Therefore, there is a growing need to offer a personalized approach for each individual patient combining early action with proactive management through the use of precision medicine tools.
In this Special Issue, recent advances and problems concerning the diagnosis and treatment of IBD will be addressed. This Special Issue will include studies on specific markers and novel pathways involved in IBD pathogenesis that may be used for an early diagnosis and/or for personalized precision medicine. Recent advances on the use of patient-derived innovative cellular models, such as organoids, to study the functional role of specific new therapeutic targets and to screen novel drugs with a direct action on intestinal epithelial cells to shift towards an individualized medicine approach in IBD will be also encouraged.
Original research articles and reviews focusing on these topics will be included in this Special Issue.
Dr. Marianna Lucafò
Prof. Dr. Giuliana Decorti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- inflammatory bowel diseases
- diagnostic biomarker
- drug discovery
- intestinal organoids
- novel therapeutic targets